Caleb Paydar

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Prognostic Factors

Prostate Cancer

Combination Therapy

Top Venues

Dermatology and therapy

Journal of comparative effectiveness research

Open access rheumatology : research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Ashis Kumar Das, Eunice Chang, Caleb Paydar, Michael S Broder, Kate K Orroth, Myriam Cordey
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic. Dermatology and therapy (2023)
Ashis Kumar Das, Eunice Chang, Caleb Paydar, Michael S Broder, Kate K Orroth, Myriam Cordey
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Verus the In-person Setting During the COVID-19 Pandemic. Dermatology and therapy (2023)
M Elaine Husni, Eunice Chang, Michael S Broder, Caleb Paydar, Katalin Bognar, Pooja Desai, Yuri Klyachkin, Ibrahim Khilfeh
Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database. Open access rheumatology : research and reviews 14 (2022)
David Kaplan, M Elaine Husni, Eunice Chang, Michael S Broder, Caleb Paydar, Katalin Bognar, Jessie Yan, Sven Richter, Pooja Desai, Ibrahim Khilfeh
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use. Journal of comparative effectiveness research 11 (8) (2022)